Figure 2 in Evaluation on reducing toxicity of fluoxastrobine with doped TiO2 nanoparticles

Figure 2. (A) LC-MS/MS spectra of 5 mg L-1 FLX with Mn–TiO in 0.15% wt v-1 catalyst in sol before irradiation and (B) after 15 h of 2 UV-C irradiation. (C) LC-MS/MS spectra of 5 mg L-1 FLX with S–TiO in 0.1%wt v-1 catalyst in sol before irradiation and (D) after 10 2 h of UV-C irradiation.